Skip to main content

Advertisement

Log in

Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging

  • Molecular Imaging
  • Published:
European Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Reference

  1. Schiepers C, Dahlbom M (2010) Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol 21:548–54, Epub 2010 Dec 21 doi:10.1007/s00330-010-2033y.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Bernd Pichler: Siemens: Consultant; Bayer HealthCare: Scientific Study/Trial; AstraZeneca: Scientific Study/Trial; Boehringer Ingelheim: Scientific Study/Trial

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Sauter.

Additional information

This journal made the decision some time ago to discourage the publication of case reports which should be directed to a teaching file such as EuroRad. However, the report in this letter confirms the use of MR/PET which is novel and it was considered that an exception might be made for this, and this only, case.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauter, A., Kolb, A., Soekler, M. et al. Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol 21, 1709–1712 (2011). https://doi.org/10.1007/s00330-011-2096-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-011-2096-4

Keywords

Navigation